WNT signaling in tumors: the way to evade drugs and immunity

E Martin-Orozco, A Sanchez-Fernandez… - Frontiers in …, 2019 - frontiersin.org
WNT/β-catenin signaling is involved in many physiological processes. Its implication in
embryonic development, cell migration, and polarization has been shown. Nevertheless …

Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis

VHL Nguyen, R Hough, S Bernaudo, C Peng - Journal of ovarian research, 2019 - Springer
Epithelial ovarian cancer (EOC) is the deadliest female malignancy. The Wnt/β-catenin
pathway plays critical roles in regulating embryonic development and physiological …

[HTML][HTML] Mechanisms of chemotherapy resistance in ovarian cancer

M Ortiz, E Wabel, K Mitchell, S Horibata - Cancer Drug Resistance, 2022 - ncbi.nlm.nih.gov
Ovarian cancer is one of the most lethal gynecologic cancers. The standard therapy for
ovarian cancer has been the same for the past two decades, a combination treatment of …

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

AG Waks, O Cohen, B Kochupurakkal, D Kim… - Annals of …, 2020 - Elsevier
Background Little is known about mechanisms of resistance to poly (adenosine diphosphate-
ribose) polymerase inhibitors (PARPi) and platinum chemotherapy in patients with …

N6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance

T Fukumoto, H Zhu, T Nacarelli, S Karakashev… - Cancer research, 2019 - AACR
Despite the high initial response rates to PARP inhibitors (PARPi) in BRCA-mutated
epithelial ovarian cancers (EOC), PARPi resistance remains a major challenge. Chemical …

Targeting fatty acid oxidation to promote anoikis and inhibit ovarian cancer progression

BT Sawyer, L Qamar, TM Yamamoto, A McMellen… - Molecular Cancer …, 2020 - AACR
Epithelial-derived high-grade serous ovarian cancer (HGSOC) is the deadliest gynecologic
malignancy. Roughly 80% of patients are diagnosed with late-stage disease, which is …

Wnts and the hallmarks of cancer

Z Zhong, J Yu, DM Virshup, B Madan - Cancer and Metastasis Reviews, 2020 - Springer
Since the discovery of the first mammalian Wnt proto-oncogene in virus-induced mouse
mammary tumors almost four decades ago, Wnt signaling pathway and its involvement in …

PARP inhibitor resistance mechanisms and implications for post-progression combination therapies

EK Lee, UA Matulonis - Cancers, 2020 - mdpi.com
The use of PARP inhibitors (PARPi) is growing widely as FDA approvals have shifted its use
from the recurrence setting to the frontline setting. In parallel, the population developing …

Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma

ZL Watson, TM Yamamoto, A McMellen, H Kim… - Clinical …, 2019 - Springer
Background Euchromatic histone-lysine-N-methyltransferases 1 and 2 (EHMT1/2, aka
GLP/G9A) catalyze dimethylation of histone H3 lysine 9 (H3K9me2) and have roles in …

Wnt signaling in gynecologic malignancies

A McMellen, ER Woodruff, BR Corr, BG Bitler… - International journal of …, 2020 - mdpi.com
Gynecologic malignancies, including ovarian cancer, endometrial cancer, and cervical
cancer, affect hundreds of thousands of women worldwide every year. Wnt signaling …